J. Hülsemann

发表

The experience of physicians in pharmacogenomic clinical decision support within eight German university hospitals.

C. Schade-Brittinger, T. Acker, F. Ückert, 2017, Pharmacogenomics.

Early arthritis and rheumatoid arthritis in Germany.

H. Zeidler, J. Hülsemann, S. Merkesdal, 2003, Clinical and experimental rheumatology.

Direct costs related to rheumatoid arthritis: the patient perspective

H. Zeidler, J. Hülsemann, T. Mittendorf, 2005, Annals of the rheumatic diseases.

Comparison of estimated medical costs among patients who are defined as having rheumatoid arthritis using three different standards

Henning Zeidler, Thomas Mittendorf, Jan L. Hülsemann, 2004, The European Journal of Health Economics, formerly: HEPAC.

Evaluation of costs in rheumatic diseases: a literature review.

G. Stucki, J. Hülsemann, J. Ruof, 1999, Current opinion in rheumatology.

Self-organized pattern formation increases functional diversity

J. Hülsemann, C. Guill, Toni Klauschies, 2020, bioRxiv.

[Early diagnosis of arthritis and spondyloarthritis within the framework of integrated health care in Lower Saxony].

S. Mattussek, H. Zeidler, J. Hülsemann, 2006, Zeitschrift fur Rheumatologie.

Diagnostic evaluation of classification criteria for rheumatoid arthritis and reactive arthritis in an early synovitis outpatient clinic

H. Zeidler, J. Hülsemann, J. Hulsemann, 1999, Annals of the rheumatic diseases.

Sustained response to tumor necrosis factor alpha-blocking agents in two patients with SAPHO syndrome.

H. Zeidler, J. Hülsemann, J. Andresen, 2002, Arthritis and rheumatism.

Unproven hypothesis that leflunomide is better than methotrexate as measured by magnetic resonance imaging: comment on the article by Reece et al.

H. Zeidler, J. Hülsemann, S. Schnarr, 2003, Arthritis and rheumatism.

Lessons from an international survey of paper cases of 10 real patients from an early arthritis clinic. CRI (Club Rhumatismes et Inflammation) Group.

F. Wolfe, B. Harrison, C. Zerbini, 2001, The Journal of rheumatology.

Undifferentiated arthritis in an early synovitis out-patient clinic.

H. Zeidler, J. Hülsemann, 1995, Clinical and experimental rheumatology.

Integrating clinical decision support systems for pharmacogenomic testing into clinical routine - a scoping review of designs of user-system interactions in recent system development

Marc Hinderer, Martin Boeker, Michael Neumaier, 2017, BMC Medical Informatics and Decision Making.

Costs of rheumatoid arthritis in Germany: a micro-costing approach based on healthcare payer’s data sources

H. Zeidler, J. Hülsemann, T. Mittendorf, 2003, Annals of the rheumatic diseases.

[Increasingly appropriate depiction of rheumatology for G-DRG reimbursement 2006].

N. Roeder, E. Märker-Hermann, J. Hülsemann, 2006, Zeitschrift fur Rheumatologie.

[The multimodal rheumatologic complex treatment (OPS 8-983)--challenges, solutions and perspectives].

N. Roeder, E. Märker-Hermann, J. Hülsemann, 2005, Zeitschrift fur Rheumatologie.

How should best strategy and tight control be translated into clinical practice? Comment on the article by Goekoop-Ruiterman et al.

H. Zeidler, J. Hülsemann, 2006, Arthritis and rheumatism.

Benign polyarthritis and undifferentiated arthritis an epidemiological terra incognita.

H. Zeidler, J. Hülsemann, 1989, Scandinavian Journal of Rheumatology. Supplement.

The Dengue ED3 Dot Assay, a Novel Serological Test for the Detection of Denguevirus Type-Specific Antibodies and Its Application in a Retrospective Seroprevalence Study

P. Buchy, J. Hülsemann, M. Schreiber, 2019, Viruses.

Undifferentiated arthritis and spondylarthropathy as a challenge for prospective follow-up

H. Zeidler, J. Hülsemann, S. Brinkmann, 1987, Clinical Rheumatology.